The Role of Real-World Evidence in Regulatory Decision-Making

  • Event Date: Jan. 29, 2021
  • Event Time: 12:00 - 12:45 p.m.
  • Event Location: 

Moderator: Mark McClellan, MD, PhD, Director, Duke-Margolis Center for Health Policy and Robert J. Margolis Professor of Business, Medicine, and Policy

  • Nancy Dreyer, PhD, MPH, Chief Scientific Officer and Senior Vice President, IQVIA
  • Jie (Jenni) Li, PhD, Associate Director for RWE, Office of Surveillance and Epidemiology, CDER FDA

Learn more about our introductory training series on Real-World Data and Real-World Evidence here

This training is funded through a Patient-Centered Outcomes Research Institute® (PCORI®) Eugene Washington PCORI Engagement Award (16203-NHC).

A special thank you to the NHC’s RWE sponsors Amgen and Eli Lilly and Co. and PCORI RWE Advisory Board members.

Sign up to receive emails about NHC programs.